pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
Drugs
by stage
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
browse
Most catalysts
Recently active
All drugs →
Companies
Patent cliff
Calendar
what
Trial readouts
PDUFA dates
Approvals
Earnings
when
Upcoming
Month grid
Recently passed
◐
Sign In
Subscribe
home
jobs
news
search
Approval · news · pharmadog
← back to Approval
News · Approval
1,551
stories
Sep 14, 26
AAM sounds alarm on ‘unsustainable, race to the bottom’ for generics and biosimilars
biospace
Sep 14, 26
As ‘cultural weight’ of a psychedelic approval looms, FDA hearing focuses on access and safety
fiercebiotech
Sep 14, 26
Kennedy to deliver keynote for anti-vaccine group he once led
stat
Sep 14, 26
AstraZeneca’s newly approved pill fails frontline breast cancer study
biopharma dive
Sep 14, 26
Summit, BioNTech, more headline WCLC with next-gen lung cancer drugs
biospace
Sep 14, 26
Definium moves toward FDA submission for LSD drug in anxiety after ‘another clear win’
biospace
Sep 14, 26
STAT+: GSK touts lung cancer data from two drugs
stat
Sep 14, 26
Novo drops ‘Nordisk’ moniker, turns bull toward future in corporate rebrand
biospace
Sep 14, 26
STAT+: Pharmalittle: We’re reading about another AstraZeneca trial failure, a Novo name change, and more
stat
Sep 14, 26
Scholar Rock SMA drug approved by FDA
biopharma dive
Sep 14, 26
AstraZeneca’s newly approved cancer pill fails late-stage study, blocking path to bigger market
biospace
Sep 14, 26
Lilly cans early experimental obesity drug after ‘high bar’ not met
fiercebiotech
Sep 14, 26
Scholar Rock secures first FDA approval for muscle-targeting rare disease drug
biospace
Sep 14, 26
Scholar Rock gets FDA nod for spinal muscular atrophy drug
endpoints
Sep 14, 26
AstraZeneca’s next-gen SERD Etcamah disappoints in untreated advanced breast cancer
endpoints
Sep 14, 26
Definium says its LSD drug notched another Phase 3 win in anxiety disorder
endpoints
Sep 14, 26
STAT+: Definium’s LSD therapy eased anxiety in second large trial
stat
Sep 14, 26
Corbus posts phase 1 obesity data for drug mechanism that defeated Novo, Sanofi
fiercebiotech
Sep 14, 26
Electra aims for $342M IPO to power inflammatory drug’s push through phase 3
fiercebiotech
Sep 14, 26
The GOP’s $50 billion rural health fund is coming up short, hospital leaders say
stat
Sep 14, 26
Roche, MediLink notch phase 3 lung cancer win but trail GSK on cross-trial survival
fiercebiotech
Sep 14, 26
Unlocking cell surface protein research with site-specific labeling
biospace
Sep 14, 26
Psychedelic therapies ride wave of public favor into FDA hearing
biospace
Sep 14, 26
5 drugmakers chasing Merck and Moderna in the cancer vaccine race
biospace
Sep 14, 26
After a brief storm of political headwinds, mRNA is back with strong momentum
biospace
Sep 14, 26
Recon: New FDA oncology chief vows continued innovation in OCE; FDA approves drugs for two rare genetic diseases
raps
Sep 14, 26
Asia-Pacific Roundup: Singapore advances legislation to build ‘more coherent, future-ready’ regulatory system
raps
Sep 12, 26
STAT+: Breast cancer pill from AstraZeneca misses mark in pivotal trial
stat
Sep 11, 26
STAT+: Scholar Rock wins FDA approval for first drug to target SMA muscle loss
stat
Sep 11, 26
FDA extends review of Exelixis' colorectal cancer drug candidate
endpoints
← prev
page 22 of 52
next →